Cell and Gene Therapy Conference Review of Phase I and II ATIR101™ data – Business Wire (press release)
|
Cell and Gene Therapy Conference Review of Phase I and II ATIR101™ data
Business Wire (press release) Kiadis Pharma is focused on cell-based immunotherapy products, as an adjunctive to a haploidentical hematopoietic stem cell transplantation (HSCT), for the treatment of blood cancers and inherited blood disorders. The Company’s product candidates have … |
Vail Daily News |
Stem cell summit brings top minds in regenerative medicine to Vail
Vail Daily News VAIL — Dr. Johnny Huard arrived at the Steadman Philippon Research Institute in 2015, and since then, the clinic’s annual Scientific Summit has become a showcase of what’s possible in the field of stem cell research. Huard is the chief scientific … |
Vail Daily News |
Stem cell summit brings top minds in regenerative medicine to Vail
Vail Daily News VAIL — Dr. Johnny Huard arrived at the Steadman Philippon Research Institute in 2015, and since then, the clinic’s annual Scientific Summit has become a showcase of what’s possible in the field of stem cell research. Huard is the chief scientific … |
Baltimore Business Journal |
Md. stem cell company using $750000 to move toward commercialization, IPO
Baltimore Business Journal … $750,000 in state funds to develop… more. Courtesy of TissueGene Inc. TissueGene Inc. was one of 29 entities to be awarded state funding through Maryland Technology Development Corp. to support research and development of stem cell therapies. |
Baltimore Business Journal |
Md. stem cell company using $750000 to move toward commercialization, IPO
Baltimore Business Journal … $750,000 in state funds to develop… more. Courtesy of TissueGene Inc. TissueGene Inc. was one of 29 entities to be awarded state funding through Maryland Technology Development Corp. to support research and development of stem cell therapies. |
SouthCoastToday.com |
Fall River lab working on cutting-edge gene therapy
SouthCoastToday.com FALL RIVER — A gene therapy treatment manufactured at MassBiologics in Fall River could soon improve quality of life for people with advanced Parkinson’s disease. The therapy is the first product to come out of the biological medicine laboratory’s … |